June 2009 Convertible Debenture Amendment
06-09-2009
Red Deer, Alberta -- Diversified Industries Ltd. (TSX Venture: DVS) is pleased to
announce it has negotiated an extension on its $550,000 convertible debenture originally
due to expire on June 9, 2009. The convertible debenture will be extended for a period
of two additional years and will have a maturity date of June 9, 2011.
The new terms include a conversion rate of $0.09 per share, exercisable at any time
(previously $0.35) an interest rate of 7% per annum, payable annually. Interest is also
convertible at the greater of market price or $0.09 per share. Interest to date on the
existing debenture has been accrued.
All debenture holders have agreed to the proposed terms and conditional approval has
been received by the TSX Venture Exchange subject to the issuance and dissemination
of this news release.
Diversified currently owns 50% of CFR Chemicals Inc with the option to own 100%. The
option price is locked in, based on profits accrued over a three year period. For complete
details of this transaction please refer to the March 21, 2007 news release.

For more information visit www.dvsind.com or www.cfrchemicals.com

On behalf of the Board of Directors:
"Darren J. Lamothe"
_____________________________
Darren J. Lamothe, President/CEO
For investor information, please contact;
Darren Lamothe, President/CEO
Tomas Marshall, CFO
Phone: (403) 346-2149
e-mail: dlamothe@cfrchemicals.com
e-mail : tmarshall@cfrchemicals.com
Parkland Mall, Suite 915
4747 – 67th Street
Red Deer, AB T4N 6H3
Statements made in this news release that relate to future plans, expectations, events or
performances are forward-looking statements. Such statements involve risks and uncertainties
and are based on current expectations. Consequently, actual results could differ materially from
the expectations expressed in these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.

Click to view PDF